BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6088057)

  • 1. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.
    Wolf D; Harris N; Rotter V
    Cell; 1984 Aug; 38(1):119-26. PubMed ID: 6088057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species.
    Wolf D; Admon S; Oren M; Rotter V
    Mol Cell Biol; 1984 Mar; 4(3):552-8. PubMed ID: 6144042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologically distinct p53 molecules generated by alternative splicing.
    Arai N; Nomura D; Yokota K; Wolf D; Brill E; Shohat O; Rotter V
    Mol Cell Biol; 1986 Sep; 6(9):3232-9. PubMed ID: 3023970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of p53 transformation-related protein in Ab-MuLV transformed cells is required for their development into lethal tumors in mice.
    Rotter V; Abutbul H; Wolf D
    Int J Cancer; 1983 Mar; 31(3):315-20. PubMed ID: 6298128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.
    Wolf D; Rotter V
    Mol Cell Biol; 1984 Jul; 4(7):1402-10. PubMed ID: 6095069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion to the nontransformed phenotype of Abelson murine leukemia virus-transformed cells and their subsequent retransformation.
    Roebroek AJ; Bloemers HP; van de Ven WJ
    Virus Res; 1986 Oct; 6(1):15-26. PubMed ID: 2432738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abelson murine leukemia virus: structural requirements for transforming gene function.
    Srinivasan A; Dunn CY; Yuasa Y; Devare SG; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5508-12. PubMed ID: 6291048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
    Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
    Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of wild-type p53 in pre-B-cell differentiation in vitro.
    Shaulsky G; Goldfinger N; Peled A; Rotter V
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8982-6. PubMed ID: 1924360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption and activation of the c-myb locus by M-MULV insertion in plasmacytoid lymphosarcomas induced by pristane and Abelson viruses.
    Shen-Ong GL; Reddy EP; Potter M; Mushinski JF
    Curr Top Microbiol Immunol; 1984; 113():41-6. PubMed ID: 6090070
    [No Abstract]   [Full Text] [Related]  

  • 13. Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.
    Srinivasan A; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2077-81. PubMed ID: 6264461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.
    Goff SP; Tabin CJ; Wang JY; Weinberg R; Baltimore D
    J Virol; 1982 Jan; 41(1):271-85. PubMed ID: 6283119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of NIH3T3 cells by A-MuLV proviral DNA: effect of plasmid linearization and carrier DNA on transformation efficiency.
    Shore SK; Reddy EP
    Oncogene; 1989 Nov; 4(11):1411-3. PubMed ID: 2554240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral insertional mutagenesis of a target allele in a heterozygous murine cell line.
    Frankel W; Potter TA; Rosenberg N; Lenz J; Rajan TV
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6600-4. PubMed ID: 2995973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.
    Rotter V; Witte ON; Coffman R; Baltimore D
    J Virol; 1980 Nov; 36(2):547-55. PubMed ID: 6159484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
    Colledge WH; Gebhardt A; Edge MD; Bell JC
    Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.